MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $336,000 | +47.4% | 6,404 | -26.2% | 0.00% | 0.0% |
| Q3 2018 | $228,000 | -24.8% | 8,672 | -41.4% | 0.00% | 0.0% |
| Q2 2018 | $303,000 | +3.8% | 14,804 | -7.9% | 0.00% | 0.0% |
| Q1 2018 | $292,000 | -15.1% | 16,079 | -34.8% | 0.00% | 0.0% |
| Q4 2017 | $344,000 | +254.6% | 24,659 | +174.1% | 0.00% | +100.0% |
| Q2 2016 | $97,000 | +27.6% | 8,996 | +8.9% | 0.00% | 0.0% |
| Q1 2016 | $76,000 | -16.5% | 8,262 | +34.9% | 0.00% | 0.0% |
| Q4 2015 | $91,000 | -28.3% | 6,126 | -21.0% | 0.00% | 0.0% |
| Q3 2015 | $127,000 | +122.8% | 7,758 | +210.9% | 0.00% | – |
| Q2 2015 | $57,000 | +159.1% | 2,495 | +72.4% | 0.00% | – |
| Q1 2015 | $22,000 | +29.4% | 1,447 | +1.1% | 0.00% | – |
| Q4 2014 | $17,000 | -10.5% | 1,431 | -16.3% | 0.00% | – |
| Q3 2014 | $19,000 | -9.5% | 1,710 | -1.3% | 0.00% | – |
| Q2 2014 | $21,000 | -4.5% | 1,733 | -8.1% | 0.00% | – |
| Q1 2014 | $22,000 | -29.0% | 1,886 | +7.4% | 0.00% | – |
| Q4 2013 | $31,000 | -65.2% | 1,756 | -71.6% | 0.00% | -100.0% |
| Q3 2013 | $89,000 | +85.4% | 6,191 | +95.2% | 0.00% | – |
| Q2 2013 | $48,000 | – | 3,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |